We thus hypothesized that targeting CS chains by knockdown of CHSY1 or treating glioma cells with C6S binding peptides may result in decreased CD44 protein levels, and inhibit the outside-in signals from regulating the gene expression of integrins. The gene discussed is CHSY1; the disease is glioma.